Massachusetts Institute Of Technology

Massachusetts Institute of Technology, operating as MIT and its subsidiaries, is a premier private research university based in Cambridge, Massachusetts, that serves as a prime contractor and recipient for federal research, development, and educational grants across 242 federal agencies. MIT competes exclusively in full-and-open procurement with no set-asides, receiving awards across fundamental research, applied development, graduate and undergraduate education, and institutional partnerships from civilian and defense agencies.

MIT's federal footprint spans 12,387 awards (94% as prime, 6% as sub) valued at $2.61 billion in potential value against $20.38 billion in total obligated dollars. The institution's award portfolio has grown from 420 awards in 2022 to 571 in 2024, though 2025-2026 activity has moderated with 449 and 135 awards respectively. Within the next twenty-four months, 545 awards valued at $279.7 million reach ultimate completion and face recompete risk.

Federal customer concentration clusters around research funding agencies. The National Science Foundation leads by award count with 1,737 grants; the Department of the Navy follows with 1,426 awards. However, potential value distribution differs: NASA Goddard Space Center anchors $290.7 million across 108 awards, with NASA Shared Services Center adding $252.6 million on 1,024 grants. Army Materiel Command's Research Development and Engineering Command places $229.9 million across 197 awards, and the Defense Advanced Research Projects Agency commits $194.5 million across 216 awards. This split reflects MIT's concurrent role as both a fundamental research partner (NSF dominance by award count) and a targeted technology developer (NASA and DoD dominance by dollars).

MIT holds positions on indefinite-delivery vehicles anchoring ongoing task-order activity. The top vehicles are N0024409G0014 (116 task orders, $28.8 million combined value), F1962885C0002 (46 task orders), N6227197G0026 (46 task orders, $3.9 million combined value), F0160079D0280 (42 task orders), and F1962880C0002 (41 task orders). These vehicles concentrate Navy and Air Force work and represent standing relationships enabling rapid task order issuance for emerging research priorities.

MIT's capability portfolio centers on fundamental and applied research across quantum computing, artificial intelligence, advanced materials, space exploration, biomedical innovation, climate science, and defense technologies. Representative prime work includes a $1.5 million DARPA Other Transaction Agreement (awarded November 2025) for high-throughput synthetic biology data generation platforms for generative AI models; a $10.091 million National Institutes of Health OTA (February 2026) for the Self-Powered, Transmitting Lacrimal Artificial Sensor project under the OCULAB program; a $2.0 million Department of Commerce contract (September 2025) for Web Accessibility Initiative support with the W3C; and a $249,903 NASA purchase order (March 2026) for physics-informed particle impact ignition model development. Educational delivery includes Naval Education and Training Command funding of $938,585 for military officer education (September 2025) and $593,168 for fall 2025 tuition support. Grant recipients include the National Cancer Institute ($100,228 for cancer immunotherapy research involving phospholipase mechanisms), the National Institute of General Medical Sciences ($440,465 for biophysical genome-folding models and $269,071 for cryo-electron microscopy of ribonucleotide reductase), the Office of Naval Research ($1.5 million for multi-agent systems and $400,000 for cooperative underwater object detection), and the National Science Foundation ($486,570 for gravitational-wave machine learning and $1.2 million for quantum cryptography foundations).

MIT operates without formal SCI-reportable invoiced revenue in the source data (FY2022–FY2024 shows $0 across the three fiscal years), though Service Contract Inventory tracking reports 44 records (38 as prime, 6 as named subcontractor) with negligible FTE commitment (2.9 FTEs in FY2022, 0 in FY2023, 5.3 in FY2024). This reflects MIT's emphasis on research grants and contracts rather than service-contract delivery models. The institution does not rely on subcontractors to deliver prime work—average sub-hours share is zero across SCI-reportable contracts, indicating integrated in-house delivery.

MIT's subcontract footprint as a performer includes sub-awards to collaborating universities and research centers. Named sub-award relationships include partnerships with Triad National Security (Los Alamos National Laboratory management competition, awarded March 2026), Honeywell Federal Manufacturing & Technologies (National Security Campus R&D, awarded January 2026), Carnegie-Mellon University (optical metamaterials and cognitive robotics research), Stanford University and other peer research universities (quantum systems development, gravitational-wave analysis, fusion workforce development), and Boston University, University of California schools, and other research institutions (collaborative research in biomedical sciences, geophysics, and advanced computing). MIT also receives sub-award funding from prime recipients including the Regents of University of Michigan (migraine phenotyping data analysis), Boston University (bacterial glycoconjugate research), and the Leland Stanford Junior University (quantum device characterization).

Corporate structure shows MIT as the parent entity with named subsidiaries including The Engine Accelerator, Inc. (for-profit accelerator), MIT's Singapore-MIT Alliance for Research and Technology Centre (non-profit research hub), and holding entities for MIT itself. The institution's nonprofit tax-exempt status as a private research university does not affect its federal contractor eligibility—awards flow directly to MIT as the implementing institution.

MIT's federal strategy reflects a premier research institution model: deep penetration into NSF, NIH, NASA, DoD, and DARPA via merit-based competitive proposal selection; sustained presence on high-value IDIQs enabling rapid task order mobilization; absence of set-aside competition (no 8(a), HUBZone, SDVOSB, or other small-business designations); and reliance on educational and collaborative partnerships rather than subcontractor supply chains. The institution's $2.61 billion potential-value portfolio against $20.38 billion obligated suggests substantial prior-year work rolling forward alongside new award activity. Recompete exposure of $279.7 million in the next twenty-four months represents material opportunity for competitors or renewal risk for MIT's existing relationships.